| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |